ArticleBMC cardiovascular disorders2025
Occurrence of sarcopenia in elderly patients with coronary heart disease and its association with short-term prognosis.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Sarcopenia as a Multisystem Disorder-Connections with Neural and Cardiovascular Systems-A Related PRISMA Systematic Literature Review.Life (Basel, Switzerland) · 2026Review
- Cachexia and Wasting in Chronic Illness: Regulatory and Clinical Trial Update.Journal of cachexia, sarcopenia and muscle · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveSarcopenia is a common complication in elderly patients with coronary heart disease (CHD). This study aims to analyse and explore the occurrence of sarcopenia in elderly patients with CHD and its associations with short-term prognosis.
methodsA total of 318 elderly patients with CHD were enrolled between March 2020 and March 2022. Sarcopenia was assessed at admission using grip strength and gait speed; subsequently, clinical data, cardiac function indicators, adverse events and mortality were compared between the two groups to explore the associations of sarcopenia with the short-term prognosis of elderly patients with CHD.
resultsAmong the 318 elderly patients with CHD included in this study, 69 developed sarcopenia, with an incidence rate of 21.70%. The sarcopenia group showed lower cardiac output and left ventricular ejection fraction levels than the non-sarcopenia group, while higher left ventricular end-diastolic diameter, left ventricular end-systolic diameter, interventricular septum thickness and left ventricular posterior wall thickness levels were greater than in the non-sarcopenia group, with p < 0.05. The sarcopenia group had higher rates of unconventional medical visits and major adverse cardiac and cerebral events compared with the non-sarcopenia group, with p < 0.05. The mortality rate in the sarcopenia group was higher than in the non-sarcopenia group, with p < 0.05.
conclusionSarcopenia is significantly associated with the short-term prognosis of elderly coronary heart disease patients, indicating the need for preventive strategies to improve clinical outcomes and extend survival.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.